Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-017655
Filing Date
2016-05-04
Accepted
2016-05-04 16:16:46
Documents
60
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rlyp-10q_20160331.htm 10-Q 1798305
2 EX-10.1 rlyp-ex101_420.htm EX-10.1 43711
3 EX-10.2 rlyp-ex102_421.htm EX-10.2 72913
4 EX-31.1 rlyp-ex311_227.htm EX-31.1 15165
5 EX-31.2 rlyp-ex312_226.htm EX-31.2 15165
6 EX-32.1 rlyp-ex321_225.htm EX-32.1 6370
  Complete submission text file 0001564590-16-017655.txt   6644233

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT rlyp-20160331.xml EX-101.INS 1525578
8 XBRL TAXONOMY EXTENSION SCHEMA rlyp-20160331.xsd EX-101.SCH 38939
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rlyp-20160331_cal.xml EX-101.CAL 47187
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rlyp-20160331_def.xml EX-101.DEF 134182
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE rlyp-20160331_lab.xml EX-101.LAB 342571
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rlyp-20160331_pre.xml EX-101.PRE 262277
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 650-421-9500
Relypsa Inc (Filer) CIK: 0001416792 (see all company filings)

EIN.: 260893742 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36184 | Film No.: 161619542
SIC: 2834 Pharmaceutical Preparations